PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.610
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
PMV Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 48.81 | 37.71 | 108.3 | 172.47 | 361.42 | 73.28 | Upgrade
|
| Short-Term Investments | 134.03 | 165.35 | 132.76 | 124.7 | - | 28.21 | Upgrade
|
| Cash & Short-Term Investments | 182.84 | 203.06 | 241.05 | 297.16 | 361.42 | 101.49 | Upgrade
|
| Cash Growth | -9.45% | -15.76% | -18.88% | -17.78% | 256.13% | 63.93% | Upgrade
|
| Prepaid Expenses | 5.96 | 3.53 | 5.13 | 3.3 | 3.34 | 0.61 | Upgrade
|
| Restricted Cash | 0.82 | 0.82 | 0.82 | 0.82 | - | - | Upgrade
|
| Total Current Assets | 189.62 | 207.41 | 247.01 | 301.29 | 364.76 | 102.09 | Upgrade
|
| Property, Plant & Equipment | 18.54 | 19.05 | 20.49 | 13.15 | 0.57 | 0.74 | Upgrade
|
| Long-Term Investments | 15.1 | 25.51 | 2.5 | 16.91 | - | - | Upgrade
|
| Other Long-Term Assets | 0.24 | 0.19 | 0.31 | 0.22 | 0.2 | 0.2 | Upgrade
|
| Total Assets | 223.5 | 252.15 | 270.31 | 331.57 | 365.53 | 103.03 | Upgrade
|
| Accounts Payable | 2.06 | 3.24 | 3 | 3.19 | 1.61 | 2.84 | Upgrade
|
| Accrued Expenses | 10.26 | 9.94 | 7.31 | 8.63 | 4.8 | 1.69 | Upgrade
|
| Current Portion of Leases | 1.24 | 0.85 | 0.53 | 0.4 | - | - | Upgrade
|
| Total Current Liabilities | 13.56 | 14.03 | 10.83 | 12.22 | 6.41 | 4.52 | Upgrade
|
| Long-Term Leases | 12.02 | 12.43 | 13.45 | 10.79 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.05 | Upgrade
|
| Total Liabilities | 25.59 | 26.46 | 24.28 | 23.01 | 6.41 | 4.57 | Upgrade
|
| Additional Paid-In Capital | 543.21 | 535.47 | 487.52 | 476.36 | 469 | 4.97 | Upgrade
|
| Retained Earnings | -345.71 | -310 | -241.04 | -167.73 | -109.88 | -75.44 | Upgrade
|
| Comprehensive Income & Other | 0.41 | 0.22 | -0.45 | -0.08 | - | -0 | Upgrade
|
| Total Common Equity | 197.91 | 225.69 | 246.03 | 308.56 | 359.12 | -70.47 | Upgrade
|
| Shareholders' Equity | 197.91 | 225.69 | 246.03 | 308.56 | 359.12 | 98.46 | Upgrade
|
| Total Liabilities & Equity | 223.5 | 252.15 | 270.31 | 331.57 | 365.53 | 103.03 | Upgrade
|
| Total Debt | 13.27 | 13.29 | 13.98 | 11.19 | - | - | Upgrade
|
| Net Cash (Debt) | 184.67 | 215.28 | 229.57 | 302.88 | 361.42 | 101.49 | Upgrade
|
| Net Cash Growth | -18.07% | -6.23% | -24.20% | -16.20% | 256.13% | 63.93% | Upgrade
|
| Net Cash Per Share | 3.59 | 4.48 | 5.04 | 6.71 | 25.16 | 33.44 | Upgrade
|
| Filing Date Shares Outstanding | 51.75 | 51.44 | 45.77 | 45.45 | 44.78 | 3.05 | Upgrade
|
| Total Common Shares Outstanding | 51.75 | 51.45 | 45.77 | 45.43 | 44.78 | 3.05 | Upgrade
|
| Working Capital | 176.06 | 193.38 | 236.17 | 289.07 | 358.35 | 97.57 | Upgrade
|
| Book Value Per Share | 3.82 | 4.39 | 5.38 | 6.79 | 8.02 | -23.13 | Upgrade
|
| Tangible Book Value | 197.91 | 225.69 | 246.03 | 308.56 | 359.12 | -70.47 | Upgrade
|
| Tangible Book Value Per Share | 3.82 | 4.39 | 5.38 | 6.79 | 8.02 | -23.13 | Upgrade
|
| Machinery | 2.81 | 3.17 | 2.53 | 2.28 | 2.01 | 1.92 | Upgrade
|
| Leasehold Improvements | 11.36 | 10.77 | 0.41 | 0.16 | 0.07 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.